SCHEMBL1072201

SCHEMBL1072201

CC(C)(C)OC(=O)/C=C/c1cc2cc(OCc3ccccc3)ccc2[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.58
SRD5A2 P31213 2/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
HPGD P15428 1/20 0.58
HSD17B10 Q99714 1/20 0.58
PDGFRB P09619 1/20 0.55
PDGFRA P16234 1/20 0.55
FLT3 P36888 1/20 0.52
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
MAOB P27338 2/20 0.46
MAOA P21397 1/20 0.46
CFD P00746 1/20 0.45
PKM P14618 1/20 0.43
ALOX5 P09917 1/20 0.43
HDAC8 Q9BY41 1/20 0.42
PTGER3 P43115 1/20 0.42
PTGDR Q13258 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1072204 1.00 KDM4E (0.58) KDM4EALDH1A1SRD5A2CYP1A2CYP2C9
SCHEMBL951357 0.86 ALDH1A1 (0.59) KDM4EALDH1A1SRD5A2CYP1A2CYP2C9
SCHEMBL951355 0.86 ALDH1A1 (0.59) KDM4EALDH1A1SRD5A2CYP1A2CYP2C9
SCHEMBL30407949 0.81 FLT3 (0.43) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL5360581 0.81 ATP6V1B1 (0.51) KDM4ESRD5A2CYP1A2CYP2C9HPGD
SCHEMBL5360579 0.81 ATP6V1B1 (0.51) KDM4ESRD5A2CYP1A2CYP2C9HPGD
SCHEMBL1745452 0.79 GSK3B (0.67) KDM4EMAOBGSK3BBACE1SLC5A1
SCHEMBL19079051 0.79 GSK3B (0.67) KDM4EMAOBGSK3BBACE1SLC5A1
SCHEMBL5947111 0.79 GSK3B (0.67) KDM4EMAOBGSK3BBACE1SLC5A1
SCHEMBL16971179 0.79 HDAC8 (0.49) KDM4EALDH1A1SRD5A2MAOBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011005295-A1 MODULATORS OF THE SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2011-01-13 WO disclosed